Ozempic Price Guide: Monthly Cost and Coverage Factors

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

A reference guide from the PlexusDx Education Hub, laying out the variables that determine what Ozempic actually costs.

Rather than a single price, Ozempic has a set of factors that combine into whatever a given patient pays. This guide walks through them in order: the published list price, the coverage variables layered on top, the savings mechanisms, and the compounded track. Reading it as a checklist makes the widely varying numbers online easier to interpret. Figures reflect April 2026.

Treating cost as a set of factors rather than a fixed figure is the whole point, because the widely different prices people quote online almost always reflect different positions on these variables rather than genuine disagreement about what the medication itself is priced at.

Factor 1: the published list price

Novo Nordisk's published list price for Ozempic is approximately $968 to $1,029 per month at U.S. list as of April 2026. This is the reference figure before any adjustment. Because rebates, insurance, and negotiation almost always intervene, most insured patients pay something different, but every other calculation begins here.

Factor 2: coverage and prior authorization

What a commercial plan pays depends on formulary placement, the FDA-approved indication on the prescription, and prior authorization criteria. Diabetes coverage is common; weight-management coverage varies and is often gated by BMI-based prior authorization or excluded entirely. Medicare does not cover weight-alone indications as of April 2026, though some cardiovascular indications are covered.

Factor 3: savings programs

The Novo Nordisk savings card can substantially lower monthly cost for eligible commercially insured patients, who may pay as little as $25 per month within program caps. Eligibility usually excludes Medicare, Medicaid, and TRICARE. Separately, GoodRx and SingleCare publish coupon prices that shift by pharmacy and suit cash-pay scenarios.

Factor 4: the compounded track

503A pharmacies compounded semaglutide and tirzepatide during the FDA-declared shortages. The semaglutide shortage resolved in late 2024 and tirzepatide in early 2025, narrowing but not eliminating legitimate compounding. Compounded products stay available through licensed pathways where justified, priced on their own structure and not classifiable as generics.

Reading a real out-of-pocket number

Combine the factors: covered indication plus savings card can produce a low monthly figure; uncovered indication pushes cash cost toward list minus a coupon; no insurance lands near list price. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, with pricing published on each product page. Reading these factors in sequence, rather than seizing on one figure, is what turns a confusing spread of online quotes into a number that actually reflects your own coverage and circumstances.

The variable a price guide cannot list

No cost table captures your own biology. Variants in MC4R and TCF7L2 influence satiety and glucose handling, shaping how a GLP-1 pathway fits you. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights as trait-level education. It never predicts response to a specific drug; it is context for a conversation with your provider before you weigh cost.

Turning the guide into a pre-visit checklist

The factors above are easier to apply if you convert them into questions before a pharmacy visit or a provider appointment. Knowing your answers in advance turns a confusing set of variables into a short, concrete list you can work through rather than a wall of pricing noise.

Start with coverage: does your plan list the medication for the FDA-approved indication on your prescription, and does it require prior authorization? Move to savings: are you eligible for the manufacturer card, and what are its current caps? Then consider alternatives: is a licensed compounded pathway relevant to your situation, and how is it priced? Finally, confirm the pharmacy-level number at the time of fill, since list price is only the anchor. Walking in with those four answers means you are interpreting a real out-of-pocket figure rather than reacting to a headline price that may not apply to your circumstances at all.

Frequently Asked Questions

What is the current list price of Ozempic?

As of April 2026, Novo Nordisk's published list price is approximately $968 to $1,029 per month at U.S. list. That figure sits before insurance, rebates, and savings cards, so it rarely equals what an insured patient pays at the counter. Verify the current price with your pharmacy before filling.

Which factors change what I pay most?

The largest swings come from whether your plan covers the prescribed FDA indication, whether you qualify for the manufacturer savings card, and your prior authorization status. Pharmacy choice and third-party coupons add smaller variation. Together these explain why quoted Ozempic prices differ so widely from patient to patient.

Does Medicare help with the cost?

Medicare does not cover FDA-approved weight-management indications for weight alone as of April 2026, and government-plan patients are generally excluded from the manufacturer savings card. Some cardiovascular indications carry coverage for certain products. Check your specific plan's formulary and criteria directly to confirm what applies.

How does genetics fit into a cost decision?

The Precision Peptide Genetic Test does not affect pricing or predict drug response. It analyzes pathway variants in genes like MC4R and TCF7L2 that shape baseline appetite and glucose biology, offering upstream context you can weigh alongside cost and coverage when discussing options with a qualified provider.

Find related coverage and savings articles at the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.